Please provide your email address to receive an email when new articles are posted on . Patients with atopic dermatitis that were resistant to systemic therapies, including dupilumab, were treated ...

A new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The current treatment options for atopic ...

Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...

Experts discuss the importance of balancing effective symptom control with quality of life in managing chronic pediatric atopic dermatitis, emphasizing personalized treatment plans that address both ...

Topical pumecitinib 3% gel shows strong efficacy and good tolerability in mild-to-moderate atopic dermatitis. Explore the ...

High-dose upadacitinib was found to be most effective in improving AD and itch severity, quality of life and AD flares, but was determined to be among the most harmful with regard to adverse events.

Patients with atopic dermatitis (AD) are at increased risk of skin infections due to impaired skin barrier function and a dysregulated immune system; extracutaneous and systemic infections may also ...

Young children with moderate-to-severe atopic dermatitis (AD) are shorter on average than their peers. Researchers hypothesized that sleep deprivation or long-term exposure to topical or systemic ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today provided an update on its test ...

Although previous research has demonstrated the superiority of various herbal medicines over comparator therapies for atopic dermatitis, there are insufficient data to warrant any specific ...